nodes	percent_of_prediction	percent_of_DWPC	metapath
Procarbazine—brain cancer—bone cancer	0.584	1	CtDrD
Procarbazine—XDH—Carboplatin—bone cancer	0.127	0.356	CbGbCtD
Procarbazine—XDH—Cisplatin—bone cancer	0.108	0.304	CbGbCtD
Procarbazine—XDH—Doxorubicin—bone cancer	0.0726	0.204	CbGbCtD
Procarbazine—CYP1B1—Doxorubicin—bone cancer	0.0482	0.136	CbGbCtD
Procarbazine—Amenorrhoea—Epirubicin—bone cancer	0.00022	0.00365	CcSEcCtD
Procarbazine—Dysarthria—Methotrexate—bone cancer	0.000218	0.00363	CcSEcCtD
Procarbazine—Petechiae—Doxorubicin—bone cancer	0.000217	0.00361	CcSEcCtD
Procarbazine—Dysphonia—Doxorubicin—bone cancer	0.000217	0.00361	CcSEcCtD
Procarbazine—Neoplasm malignant—Doxorubicin—bone cancer	0.00021	0.00348	CcSEcCtD
Procarbazine—Nocturia—Epirubicin—bone cancer	0.000208	0.00346	CcSEcCtD
Procarbazine—Neuropathy peripheral—Cisplatin—bone cancer	0.000206	0.00343	CcSEcCtD
Procarbazine—Stomatitis—Cisplatin—bone cancer	0.000205	0.00341	CcSEcCtD
Procarbazine—Dysarthria—Epirubicin—bone cancer	0.000204	0.00339	CcSEcCtD
Procarbazine—Amenorrhoea—Doxorubicin—bone cancer	0.000204	0.00338	CcSEcCtD
Procarbazine—Melaena—Methotrexate—bone cancer	0.000202	0.00335	CcSEcCtD
Procarbazine—Nocturia—Doxorubicin—bone cancer	0.000193	0.0032	CcSEcCtD
Procarbazine—Dysarthria—Doxorubicin—bone cancer	0.000189	0.00314	CcSEcCtD
Procarbazine—Melaena—Epirubicin—bone cancer	0.000189	0.00314	CcSEcCtD
Procarbazine—Coma—Methotrexate—bone cancer	0.000189	0.00313	CcSEcCtD
Procarbazine—Gynaecomastia—Methotrexate—bone cancer	0.000185	0.00307	CcSEcCtD
Procarbazine—Neuropathy—Epirubicin—bone cancer	0.000182	0.00301	CcSEcCtD
Procarbazine—Coma—Epirubicin—bone cancer	0.000177	0.00293	CcSEcCtD
Procarbazine—Flushing—Cisplatin—bone cancer	0.000175	0.00291	CcSEcCtD
Procarbazine—Melaena—Doxorubicin—bone cancer	0.000175	0.0029	CcSEcCtD
Procarbazine—Photosensitivity—Methotrexate—bone cancer	0.000171	0.00284	CcSEcCtD
Procarbazine—Arrhythmia—Cisplatin—bone cancer	0.000169	0.0028	CcSEcCtD
Procarbazine—Neuropathy—Doxorubicin—bone cancer	0.000168	0.00279	CcSEcCtD
Procarbazine—Alopecia—Cisplatin—bone cancer	0.000167	0.00277	CcSEcCtD
Procarbazine—Coma—Doxorubicin—bone cancer	0.000163	0.00271	CcSEcCtD
Procarbazine—Hepatic function abnormal—Epirubicin—bone cancer	0.000161	0.00267	CcSEcCtD
Procarbazine—Photosensitivity—Epirubicin—bone cancer	0.00016	0.00265	CcSEcCtD
Procarbazine—Vascular purpura—Epirubicin—bone cancer	0.000157	0.00261	CcSEcCtD
Procarbazine—Tremor—Cisplatin—bone cancer	0.000154	0.00256	CcSEcCtD
Procarbazine—Lethargy—Methotrexate—bone cancer	0.000153	0.00254	CcSEcCtD
Procarbazine—Anaemia—Cisplatin—bone cancer	0.000152	0.00253	CcSEcCtD
Procarbazine—Hepatic function abnormal—Doxorubicin—bone cancer	0.000149	0.00247	CcSEcCtD
Procarbazine—Photosensitivity—Doxorubicin—bone cancer	0.000148	0.00246	CcSEcCtD
Procarbazine—Leukopenia—Cisplatin—bone cancer	0.000147	0.00245	CcSEcCtD
Procarbazine—Purpura—Epirubicin—bone cancer	0.000146	0.00242	CcSEcCtD
Procarbazine—Vascular purpura—Doxorubicin—bone cancer	0.000145	0.00241	CcSEcCtD
Procarbazine—Lethargy—Epirubicin—bone cancer	0.000143	0.00238	CcSEcCtD
Procarbazine—Convulsion—Cisplatin—bone cancer	0.000143	0.00237	CcSEcCtD
Procarbazine—Ataxia—Methotrexate—bone cancer	0.000141	0.00234	CcSEcCtD
Procarbazine—Diplopia—Epirubicin—bone cancer	0.00014	0.00233	CcSEcCtD
Procarbazine—Myalgia—Cisplatin—bone cancer	0.00014	0.00233	CcSEcCtD
Procarbazine—Anxiety—Cisplatin—bone cancer	0.00014	0.00232	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000135	0.00224	CcSEcCtD
Procarbazine—Purpura—Doxorubicin—bone cancer	0.000135	0.00224	CcSEcCtD
Procarbazine—Oedema—Cisplatin—bone cancer	0.000134	0.00223	CcSEcCtD
Procarbazine—Infection—Cisplatin—bone cancer	0.000133	0.00222	CcSEcCtD
Procarbazine—Lethargy—Doxorubicin—bone cancer	0.000133	0.0022	CcSEcCtD
Procarbazine—Ataxia—Epirubicin—bone cancer	0.000132	0.00219	CcSEcCtD
Procarbazine—Thrombocytopenia—Cisplatin—bone cancer	0.000132	0.00218	CcSEcCtD
Procarbazine—Tachycardia—Cisplatin—bone cancer	0.000131	0.00218	CcSEcCtD
Procarbazine—Diplopia—Doxorubicin—bone cancer	0.00013	0.00216	CcSEcCtD
Procarbazine—Hyperhidrosis—Cisplatin—bone cancer	0.00013	0.00216	CcSEcCtD
Procarbazine—Eosinophilia—Methotrexate—bone cancer	0.000128	0.00213	CcSEcCtD
Procarbazine—Anorexia—Cisplatin—bone cancer	0.000128	0.00213	CcSEcCtD
Procarbazine—Pancreatitis—Methotrexate—bone cancer	0.000127	0.00211	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000126	0.0021	CcSEcCtD
Procarbazine—Hypotension—Cisplatin—bone cancer	0.000126	0.00208	CcSEcCtD
Procarbazine—Pancytopenia—Methotrexate—bone cancer	0.000123	0.00204	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000122	0.00203	CcSEcCtD
Procarbazine—Ataxia—Doxorubicin—bone cancer	0.000122	0.00203	CcSEcCtD
Procarbazine—Dysphagia—Epirubicin—bone cancer	0.000121	0.00201	CcSEcCtD
Procarbazine—Paraesthesia—Cisplatin—bone cancer	0.000121	0.002	CcSEcCtD
Procarbazine—Eosinophilia—Epirubicin—bone cancer	0.00012	0.00199	CcSEcCtD
Procarbazine—Pancreatitis—Epirubicin—bone cancer	0.000119	0.00197	CcSEcCtD
Procarbazine—Photosensitivity reaction—Methotrexate—bone cancer	0.000118	0.00196	CcSEcCtD
Procarbazine—Angina pectoris—Epirubicin—bone cancer	0.000118	0.00196	CcSEcCtD
Procarbazine—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000117	0.00194	CcSEcCtD
Procarbazine—Decreased appetite—Cisplatin—bone cancer	0.000117	0.00194	CcSEcCtD
Procarbazine—Pneumonia—Methotrexate—bone cancer	0.000116	0.00193	CcSEcCtD
Procarbazine—Drowsiness—Methotrexate—bone cancer	0.000116	0.00192	CcSEcCtD
Procarbazine—Pancytopenia—Epirubicin—bone cancer	0.000115	0.00191	CcSEcCtD
Procarbazine—Pain—Cisplatin—bone cancer	0.000115	0.00191	CcSEcCtD
Procarbazine—Stomatitis—Methotrexate—bone cancer	0.000113	0.00187	CcSEcCtD
Procarbazine—Dysphagia—Doxorubicin—bone cancer	0.000112	0.00186	CcSEcCtD
Procarbazine—Pollakiuria—Epirubicin—bone cancer	0.000112	0.00186	CcSEcCtD
Procarbazine—Eosinophilia—Doxorubicin—bone cancer	0.000111	0.00185	CcSEcCtD
Procarbazine—Sweating—Methotrexate—bone cancer	0.000111	0.00184	CcSEcCtD
Procarbazine—Photosensitivity reaction—Epirubicin—bone cancer	0.000111	0.00184	CcSEcCtD
Procarbazine—Feeling abnormal—Cisplatin—bone cancer	0.000111	0.00184	CcSEcCtD
Procarbazine—Haematuria—Methotrexate—bone cancer	0.00011	0.00183	CcSEcCtD
Procarbazine—Pancreatitis—Doxorubicin—bone cancer	0.00011	0.00183	CcSEcCtD
Procarbazine—Angina pectoris—Doxorubicin—bone cancer	0.000109	0.00182	CcSEcCtD
Procarbazine—Epistaxis—Methotrexate—bone cancer	0.000109	0.00181	CcSEcCtD
Procarbazine—Pneumonia—Epirubicin—bone cancer	0.000109	0.00181	CcSEcCtD
Procarbazine—Drowsiness—Epirubicin—bone cancer	0.000108	0.0018	CcSEcCtD
Procarbazine—Pancytopenia—Doxorubicin—bone cancer	0.000107	0.00177	CcSEcCtD
Procarbazine—Body temperature increased—Cisplatin—bone cancer	0.000106	0.00176	CcSEcCtD
Procarbazine—Neuropathy peripheral—Epirubicin—bone cancer	0.000106	0.00176	CcSEcCtD
Procarbazine—Jaundice—Epirubicin—bone cancer	0.000105	0.00175	CcSEcCtD
Procarbazine—Stomatitis—Epirubicin—bone cancer	0.000105	0.00175	CcSEcCtD
Procarbazine—Haemoglobin—Methotrexate—bone cancer	0.000104	0.00173	CcSEcCtD
Procarbazine—Haemorrhage—Methotrexate—bone cancer	0.000104	0.00172	CcSEcCtD
Procarbazine—Sweating—Epirubicin—bone cancer	0.000104	0.00172	CcSEcCtD
Procarbazine—Pollakiuria—Doxorubicin—bone cancer	0.000104	0.00172	CcSEcCtD
Procarbazine—Haematuria—Epirubicin—bone cancer	0.000103	0.00171	CcSEcCtD
Procarbazine—Photosensitivity reaction—Doxorubicin—bone cancer	0.000102	0.0017	CcSEcCtD
Procarbazine—Epistaxis—Epirubicin—bone cancer	0.000102	0.00169	CcSEcCtD
Procarbazine—Pneumonia—Doxorubicin—bone cancer	0.000101	0.00167	CcSEcCtD
Procarbazine—Drowsiness—Doxorubicin—bone cancer	0.0001	0.00166	CcSEcCtD
Procarbazine—Hypersensitivity—Cisplatin—bone cancer	9.9e-05	0.00164	CcSEcCtD
Procarbazine—Neuropathy peripheral—Doxorubicin—bone cancer	9.81e-05	0.00163	CcSEcCtD
Procarbazine—Haemoglobin—Epirubicin—bone cancer	9.76e-05	0.00162	CcSEcCtD
Procarbazine—Stomatitis—Doxorubicin—bone cancer	9.76e-05	0.00162	CcSEcCtD
Procarbazine—Jaundice—Doxorubicin—bone cancer	9.76e-05	0.00162	CcSEcCtD
Procarbazine—Haemorrhage—Epirubicin—bone cancer	9.71e-05	0.00161	CcSEcCtD
Procarbazine—Asthenia—Cisplatin—bone cancer	9.64e-05	0.0016	CcSEcCtD
Procarbazine—Sweating—Doxorubicin—bone cancer	9.6e-05	0.00159	CcSEcCtD
Procarbazine—Haematuria—Doxorubicin—bone cancer	9.54e-05	0.00158	CcSEcCtD
Procarbazine—Epistaxis—Doxorubicin—bone cancer	9.44e-05	0.00157	CcSEcCtD
Procarbazine—Chills—Methotrexate—bone cancer	9.31e-05	0.00155	CcSEcCtD
Procarbazine—Diarrhoea—Cisplatin—bone cancer	9.19e-05	0.00153	CcSEcCtD
Procarbazine—Alopecia—Methotrexate—bone cancer	9.17e-05	0.00152	CcSEcCtD
Procarbazine—Haemoglobin—Doxorubicin—bone cancer	9.03e-05	0.0015	CcSEcCtD
Procarbazine—Flushing—Epirubicin—bone cancer	9.01e-05	0.0015	CcSEcCtD
Procarbazine—Haemorrhage—Doxorubicin—bone cancer	8.99e-05	0.00149	CcSEcCtD
Procarbazine—Chills—Epirubicin—bone cancer	8.71e-05	0.00145	CcSEcCtD
Procarbazine—Arrhythmia—Epirubicin—bone cancer	8.68e-05	0.00144	CcSEcCtD
Procarbazine—Alopecia—Epirubicin—bone cancer	8.58e-05	0.00142	CcSEcCtD
Procarbazine—Vomiting—Cisplatin—bone cancer	8.54e-05	0.00142	CcSEcCtD
Procarbazine—Rash—Cisplatin—bone cancer	8.47e-05	0.00141	CcSEcCtD
Procarbazine—Dermatitis—Cisplatin—bone cancer	8.46e-05	0.00141	CcSEcCtD
Procarbazine—Anaemia—Methotrexate—bone cancer	8.35e-05	0.00139	CcSEcCtD
Procarbazine—Flushing—Doxorubicin—bone cancer	8.34e-05	0.00138	CcSEcCtD
Procarbazine—Tension—Epirubicin—bone cancer	8.3e-05	0.00138	CcSEcCtD
Procarbazine—Nervousness—Epirubicin—bone cancer	8.21e-05	0.00136	CcSEcCtD
Procarbazine—Leukopenia—Methotrexate—bone cancer	8.09e-05	0.00134	CcSEcCtD
Procarbazine—Chills—Doxorubicin—bone cancer	8.06e-05	0.00134	CcSEcCtD
Procarbazine—Arrhythmia—Doxorubicin—bone cancer	8.03e-05	0.00133	CcSEcCtD
Procarbazine—Nausea—Cisplatin—bone cancer	7.98e-05	0.00132	CcSEcCtD
Procarbazine—Alopecia—Doxorubicin—bone cancer	7.94e-05	0.00132	CcSEcCtD
Procarbazine—Cough—Methotrexate—bone cancer	7.88e-05	0.00131	CcSEcCtD
Procarbazine—Convulsion—Methotrexate—bone cancer	7.83e-05	0.0013	CcSEcCtD
Procarbazine—Anaemia—Epirubicin—bone cancer	7.81e-05	0.0013	CcSEcCtD
Procarbazine—Myalgia—Methotrexate—bone cancer	7.69e-05	0.00128	CcSEcCtD
Procarbazine—Arthralgia—Methotrexate—bone cancer	7.69e-05	0.00128	CcSEcCtD
Procarbazine—Tension—Doxorubicin—bone cancer	7.68e-05	0.00127	CcSEcCtD
Procarbazine—Nervousness—Doxorubicin—bone cancer	7.6e-05	0.00126	CcSEcCtD
Procarbazine—Syncope—Epirubicin—bone cancer	7.58e-05	0.00126	CcSEcCtD
Procarbazine—Leukopenia—Epirubicin—bone cancer	7.57e-05	0.00126	CcSEcCtD
Procarbazine—Confusional state—Methotrexate—bone cancer	7.43e-05	0.00123	CcSEcCtD
Procarbazine—Loss of consciousness—Epirubicin—bone cancer	7.43e-05	0.00123	CcSEcCtD
Procarbazine—Cough—Epirubicin—bone cancer	7.38e-05	0.00122	CcSEcCtD
Procarbazine—Convulsion—Epirubicin—bone cancer	7.32e-05	0.00122	CcSEcCtD
Procarbazine—Infection—Methotrexate—bone cancer	7.32e-05	0.00122	CcSEcCtD
Procarbazine—Hypertension—Epirubicin—bone cancer	7.3e-05	0.00121	CcSEcCtD
Procarbazine—Anaemia—Doxorubicin—bone cancer	7.23e-05	0.0012	CcSEcCtD
Procarbazine—Thrombocytopenia—Methotrexate—bone cancer	7.22e-05	0.0012	CcSEcCtD
Procarbazine—Myalgia—Epirubicin—bone cancer	7.2e-05	0.00119	CcSEcCtD
Procarbazine—Arthralgia—Epirubicin—bone cancer	7.2e-05	0.00119	CcSEcCtD
Procarbazine—Anxiety—Epirubicin—bone cancer	7.17e-05	0.00119	CcSEcCtD
Procarbazine—Hyperhidrosis—Methotrexate—bone cancer	7.13e-05	0.00118	CcSEcCtD
Procarbazine—Dry mouth—Epirubicin—bone cancer	7.04e-05	0.00117	CcSEcCtD
Procarbazine—Anorexia—Methotrexate—bone cancer	7.03e-05	0.00117	CcSEcCtD
Procarbazine—Syncope—Doxorubicin—bone cancer	7.01e-05	0.00116	CcSEcCtD
Procarbazine—Leukopenia—Doxorubicin—bone cancer	7e-05	0.00116	CcSEcCtD
Procarbazine—Confusional state—Epirubicin—bone cancer	6.96e-05	0.00115	CcSEcCtD
Procarbazine—Oedema—Epirubicin—bone cancer	6.9e-05	0.00115	CcSEcCtD
Procarbazine—Hypotension—Methotrexate—bone cancer	6.89e-05	0.00114	CcSEcCtD
Procarbazine—Loss of consciousness—Doxorubicin—bone cancer	6.87e-05	0.00114	CcSEcCtD
Procarbazine—Infection—Epirubicin—bone cancer	6.85e-05	0.00114	CcSEcCtD
Procarbazine—Cough—Doxorubicin—bone cancer	6.83e-05	0.00113	CcSEcCtD
Procarbazine—Shock—Epirubicin—bone cancer	6.79e-05	0.00113	CcSEcCtD
Procarbazine—Convulsion—Doxorubicin—bone cancer	6.78e-05	0.00113	CcSEcCtD
Procarbazine—Thrombocytopenia—Epirubicin—bone cancer	6.76e-05	0.00112	CcSEcCtD
Procarbazine—Hypertension—Doxorubicin—bone cancer	6.75e-05	0.00112	CcSEcCtD
Procarbazine—Tachycardia—Epirubicin—bone cancer	6.73e-05	0.00112	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Methotrexate—bone cancer	6.72e-05	0.00112	CcSEcCtD
Procarbazine—Hyperhidrosis—Epirubicin—bone cancer	6.67e-05	0.00111	CcSEcCtD
Procarbazine—Insomnia—Methotrexate—bone cancer	6.67e-05	0.00111	CcSEcCtD
Procarbazine—Arthralgia—Doxorubicin—bone cancer	6.66e-05	0.00111	CcSEcCtD
Procarbazine—Myalgia—Doxorubicin—bone cancer	6.66e-05	0.00111	CcSEcCtD
Procarbazine—Anxiety—Doxorubicin—bone cancer	6.64e-05	0.0011	CcSEcCtD
Procarbazine—Paraesthesia—Methotrexate—bone cancer	6.62e-05	0.0011	CcSEcCtD
Procarbazine—Anorexia—Epirubicin—bone cancer	6.58e-05	0.00109	CcSEcCtD
Procarbazine—Somnolence—Methotrexate—bone cancer	6.55e-05	0.00109	CcSEcCtD
Procarbazine—Dry mouth—Doxorubicin—bone cancer	6.51e-05	0.00108	CcSEcCtD
Procarbazine—Hypotension—Epirubicin—bone cancer	6.45e-05	0.00107	CcSEcCtD
Procarbazine—Confusional state—Doxorubicin—bone cancer	6.44e-05	0.00107	CcSEcCtD
Procarbazine—Decreased appetite—Methotrexate—bone cancer	6.41e-05	0.00106	CcSEcCtD
Procarbazine—Oedema—Doxorubicin—bone cancer	6.38e-05	0.00106	CcSEcCtD
Procarbazine—Fatigue—Methotrexate—bone cancer	6.36e-05	0.00106	CcSEcCtD
Procarbazine—Infection—Doxorubicin—bone cancer	6.34e-05	0.00105	CcSEcCtD
Procarbazine—Pain—Methotrexate—bone cancer	6.3e-05	0.00105	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Epirubicin—bone cancer	6.29e-05	0.00104	CcSEcCtD
Procarbazine—Shock—Doxorubicin—bone cancer	6.28e-05	0.00104	CcSEcCtD
Procarbazine—Thrombocytopenia—Doxorubicin—bone cancer	6.25e-05	0.00104	CcSEcCtD
Procarbazine—Insomnia—Epirubicin—bone cancer	6.24e-05	0.00104	CcSEcCtD
Procarbazine—Tachycardia—Doxorubicin—bone cancer	6.23e-05	0.00103	CcSEcCtD
Procarbazine—Paraesthesia—Epirubicin—bone cancer	6.2e-05	0.00103	CcSEcCtD
Procarbazine—Hyperhidrosis—Doxorubicin—bone cancer	6.17e-05	0.00102	CcSEcCtD
Procarbazine—Somnolence—Epirubicin—bone cancer	6.13e-05	0.00102	CcSEcCtD
Procarbazine—Anorexia—Doxorubicin—bone cancer	6.08e-05	0.00101	CcSEcCtD
Procarbazine—Feeling abnormal—Methotrexate—bone cancer	6.08e-05	0.00101	CcSEcCtD
Procarbazine—Gastrointestinal pain—Methotrexate—bone cancer	6.03e-05	0.001	CcSEcCtD
Procarbazine—Decreased appetite—Epirubicin—bone cancer	6e-05	0.000996	CcSEcCtD
Procarbazine—Hypotension—Doxorubicin—bone cancer	5.97e-05	0.00099	CcSEcCtD
Procarbazine—Fatigue—Epirubicin—bone cancer	5.95e-05	0.000988	CcSEcCtD
Procarbazine—Pain—Epirubicin—bone cancer	5.9e-05	0.00098	CcSEcCtD
Procarbazine—Constipation—Epirubicin—bone cancer	5.9e-05	0.00098	CcSEcCtD
Procarbazine—Urticaria—Methotrexate—bone cancer	5.86e-05	0.000972	CcSEcCtD
Procarbazine—Body temperature increased—Methotrexate—bone cancer	5.83e-05	0.000968	CcSEcCtD
Procarbazine—Abdominal pain—Methotrexate—bone cancer	5.83e-05	0.000968	CcSEcCtD
Procarbazine—Musculoskeletal discomfort—Doxorubicin—bone cancer	5.82e-05	0.000966	CcSEcCtD
Procarbazine—Insomnia—Doxorubicin—bone cancer	5.77e-05	0.000959	CcSEcCtD
Procarbazine—Paraesthesia—Doxorubicin—bone cancer	5.73e-05	0.000952	CcSEcCtD
Procarbazine—Feeling abnormal—Epirubicin—bone cancer	5.69e-05	0.000944	CcSEcCtD
Procarbazine—Somnolence—Doxorubicin—bone cancer	5.68e-05	0.000942	CcSEcCtD
Procarbazine—Gastrointestinal pain—Epirubicin—bone cancer	5.64e-05	0.000937	CcSEcCtD
Procarbazine—Decreased appetite—Doxorubicin—bone cancer	5.55e-05	0.000921	CcSEcCtD
Procarbazine—Fatigue—Doxorubicin—bone cancer	5.5e-05	0.000914	CcSEcCtD
Procarbazine—Urticaria—Epirubicin—bone cancer	5.48e-05	0.00091	CcSEcCtD
Procarbazine—Constipation—Doxorubicin—bone cancer	5.46e-05	0.000906	CcSEcCtD
Procarbazine—Pain—Doxorubicin—bone cancer	5.46e-05	0.000906	CcSEcCtD
Procarbazine—Abdominal pain—Epirubicin—bone cancer	5.45e-05	0.000906	CcSEcCtD
Procarbazine—Body temperature increased—Epirubicin—bone cancer	5.45e-05	0.000906	CcSEcCtD
Procarbazine—Hypersensitivity—Methotrexate—bone cancer	5.43e-05	0.000902	CcSEcCtD
Procarbazine—Asthenia—Methotrexate—bone cancer	5.29e-05	0.000878	CcSEcCtD
Procarbazine—Feeling abnormal—Doxorubicin—bone cancer	5.26e-05	0.000873	CcSEcCtD
Procarbazine—Gastrointestinal pain—Doxorubicin—bone cancer	5.22e-05	0.000867	CcSEcCtD
Procarbazine—Pruritus—Methotrexate—bone cancer	5.22e-05	0.000866	CcSEcCtD
Procarbazine—Hypersensitivity—Epirubicin—bone cancer	5.08e-05	0.000844	CcSEcCtD
Procarbazine—Urticaria—Doxorubicin—bone cancer	5.07e-05	0.000842	CcSEcCtD
Procarbazine—Abdominal pain—Doxorubicin—bone cancer	5.05e-05	0.000838	CcSEcCtD
Procarbazine—Body temperature increased—Doxorubicin—bone cancer	5.05e-05	0.000838	CcSEcCtD
Procarbazine—Diarrhoea—Methotrexate—bone cancer	5.04e-05	0.000837	CcSEcCtD
Procarbazine—Asthenia—Epirubicin—bone cancer	4.95e-05	0.000822	CcSEcCtD
Procarbazine—Pruritus—Epirubicin—bone cancer	4.88e-05	0.00081	CcSEcCtD
Procarbazine—Dizziness—Methotrexate—bone cancer	4.88e-05	0.000809	CcSEcCtD
Procarbazine—Diarrhoea—Epirubicin—bone cancer	4.72e-05	0.000784	CcSEcCtD
Procarbazine—Hypersensitivity—Doxorubicin—bone cancer	4.7e-05	0.000781	CcSEcCtD
Procarbazine—Vomiting—Methotrexate—bone cancer	4.69e-05	0.000778	CcSEcCtD
Procarbazine—Rash—Methotrexate—bone cancer	4.65e-05	0.000772	CcSEcCtD
Procarbazine—Dermatitis—Methotrexate—bone cancer	4.64e-05	0.000771	CcSEcCtD
Procarbazine—Headache—Methotrexate—bone cancer	4.62e-05	0.000767	CcSEcCtD
Procarbazine—Asthenia—Doxorubicin—bone cancer	4.58e-05	0.00076	CcSEcCtD
Procarbazine—Dizziness—Epirubicin—bone cancer	4.56e-05	0.000757	CcSEcCtD
Procarbazine—Pruritus—Doxorubicin—bone cancer	4.52e-05	0.00075	CcSEcCtD
Procarbazine—Vomiting—Epirubicin—bone cancer	4.39e-05	0.000728	CcSEcCtD
Procarbazine—Nausea—Methotrexate—bone cancer	4.38e-05	0.000727	CcSEcCtD
Procarbazine—Diarrhoea—Doxorubicin—bone cancer	4.37e-05	0.000725	CcSEcCtD
Procarbazine—Rash—Epirubicin—bone cancer	4.35e-05	0.000722	CcSEcCtD
Procarbazine—Dermatitis—Epirubicin—bone cancer	4.35e-05	0.000722	CcSEcCtD
Procarbazine—Headache—Epirubicin—bone cancer	4.32e-05	0.000718	CcSEcCtD
Procarbazine—Dizziness—Doxorubicin—bone cancer	4.22e-05	0.000701	CcSEcCtD
Procarbazine—Nausea—Epirubicin—bone cancer	4.1e-05	0.00068	CcSEcCtD
Procarbazine—Vomiting—Doxorubicin—bone cancer	4.06e-05	0.000674	CcSEcCtD
Procarbazine—Rash—Doxorubicin—bone cancer	4.02e-05	0.000668	CcSEcCtD
Procarbazine—Dermatitis—Doxorubicin—bone cancer	4.02e-05	0.000668	CcSEcCtD
Procarbazine—Headache—Doxorubicin—bone cancer	4e-05	0.000664	CcSEcCtD
Procarbazine—Nausea—Doxorubicin—bone cancer	3.79e-05	0.00063	CcSEcCtD
